Pii: S0304-3959(01)00333-5
نویسندگان
چکیده
Fear-avoidance beliefs have been identified as an important psychosocial variable in patients with chronic disability doe to low back pain. The importance of fear-avoidance beliefs for individuals with acute low back pain has not been explored. Seventy-eight subjects with workrelated low back pain of less than 3 weeks’duration were studied. Measurements of pain intensity, physical impairment, disability, nonorganic signs and symptoms, and depression were taken at the initial evaluation. Fear-avoidance beliefs were measured with the work and physical activity subscales of the Fear-avoidance Beliefs Questionnaire. Disability and work status were re-assessed after 4 weeks of physical therapy. Patterns of correlation between fear-avoidance beliefs and other concurrently-measured variables were similar to those reported in patients with chronic low back pain. Fear-avoidance beliefs did not explain a significant amount of the variability in initial disability levels after controlling for pain intensity and physical impairment. Fear-avoidance beliefs about work were significant predictors of 4-week disability and work status even after controlling for initial levels of pain intensity, physical impairment, and disability, and the type of therapy received. Fear-avoidance beliefs are present in patients with acute low back pain, and may be an important factor in explaining the transition from acute to chronic conditions. Screening for fear-avoidance beliefs may be useful for identifying patients at risk of prolonged disability and work absence. q 2001 International Association for the Study of Pain. Published by Elsevier Science B.V. All rights reserved.
منابع مشابه
Pii: S0304-3959(01)00292-5
For 20 years, botulinum toxin A has been used for treating a variety of disorders characterized by pathologically increased muscle contraction. Current research efforts focus on new areas of application for botulinum toxin A in speci®c pain therapy, particularly in primary headache syndromes and in myofascial pain syndromes of the neck, shoulder girdle and back. This opens up new options for pa...
متن کاملDrawing new GM battle lines
The legal battles over GM crop trials in Europe are hotting up, reports Nigel Williams.
متن کاملPii: S0304-3959(01)00358-x
A clinical study tested the therapeutic efficacy of Botulinum toxin A (BTXA) when injected into symptomatic neck muscles after one injection session. Patients with chronic neck pain were randomly assigned to receive either a high dose of an active treatment or an injection of the same volume of normal saline. Patients were compared for 4 months using a comprehensive set of outcome measures that...
متن کامل